ARTICLE | Company News
Vertex, Trek Therapeutics deal
August 1, 2016 7:00 AM UTC
Vertex granted Trek exclusive, worldwide rights to develop and commercialize lomibuvir ( VX-222) and merimepodib ( VX-497) to treat infectious disease. Vertex is eligible for undisclosed milestones an...